论文部分内容阅读
目的 :评价注射用阿奇霉素治疗细菌性感染的有效性及安全性。方法 :6 0例呼吸系统和泌尿系统细菌感染性疾病患者随机分为治疗组和对照组 ,每组 30例 ,治疗组静滴阿奇霉素 2 5 0mg ,qd ,疗程 5d。对照组静滴头孢噻肟钠 2g ,qd ,疗程 7d。结果 :治疗组与对照组治疗细菌感染性疾病的有效率分别为 90 .0 %与 80 .0 % ,两组比较无统计学差异 (P >0 .0 5 ) ;细菌清除率分别为 89.3%与 6 2 .1% ,两组比较有统计学差异 (P <0 .0 5 ) ;不良反应发生率均为 6 .7%。结论 :注射用阿奇霉素治疗细菌性感染疗效高、安全性好。
Objective: To evaluate the efficacy and safety of azithromycin in the treatment of bacterial infections. Methods: Sixty patients with respiratory and urinary tract bacterial infections were randomly divided into treatment group (n = 30) and control group (n = 30). The treatment group received azithromycin 250 mg qd for 5 days. Control group intravenous cefotaxime sodium 2g, qd, treatment 7d. Results: The effective rates of treatment of bacterial infections in treatment group and control group were 90.0% and 80.0% respectively, there was no significant difference between the two groups (P> 0.05); the bacterial clearance rates were 89.3% And 62.1% respectively, with statistical difference (P <0.05). The incidence of adverse reactions was 6.7%. Conclusion: Azithromycin for the treatment of bacterial infections with high efficacy and safety.